TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 71)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 DRUG SCREENING MARKET: MARKETS COVERED
1.3.2 REGIONS COVERED
FIGURE 2 DRUG SCREENING INDUSTRY: REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 77)
2.1 RESEARCH DATA
FIGURE 3 DRUG SCREENING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
FIGURE 4 DRUG SCREENING INDUSTRY: KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
FIGURE 5 MARKET: PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 6 MARKET: KEY DATA FROM PRIMARY SOURCES
2.1.2.2 Key industry insights
FIGURE 7 MARKET: KEY INDUSTRY INSIGHTS
2.1.2.3 Breakdown of primary interviews
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY, DESIGNATION, AND REGION
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 TOTAL MARKET SIZE ESTIMATION
2.2.2 REVENUE SHARE ANALYSIS
FIGURE 10 MARKET SIZE ESTIMATION (SUPPLY SIDE): REVENUE SHARE ANALYSIS
2.2.3 BOTTOM-UP APPROACH
FIGURE 11 MARKET: BOTTOM-UP APPROACH
2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.5 TOP-DOWN APPROACH
FIGURE 12 MARKET: TOP-DOWN APPROACH
2.3 MARKET GROWTH FORECAST
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 15 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
TABLE 1 MARKET: STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 MARKET: RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 IMPACT OF ECONOMIC RECESSION ON MARKET
3 EXECUTIVE SUMMARY (Page No. - 92)
FIGURE 16 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
FIGURE 17 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 18 DRUG SCREENING INDUSTRY, BY DRUG TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 19 MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 20 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 21 REGIONAL SEGMENTATION OF MARKET
4 PREMIUM INSIGHTS (Page No. - 97)
4.1 DRUG SCREENING MARKET OVERVIEW
FIGURE 22 GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET
4.2 NORTH AMERICA: DRUG SCREENING INDUSTRY, BY PRODUCT & SERVICE AND COUNTRY (2023)
FIGURE 23 US AND DRUG SCREENING SERVICES TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
4.3 MARKET: REGIONAL MIX (2022–2029)
FIGURE 24 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
4.4 MARKET: GEOGRAPHICAL SNAPSHOT (2024–2029)
FIGURE 25 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES (2024 VS. 2029)
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 100)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 27 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing consumption of illicit drugs and alcohol
5.2.1.2 Enforcement of stringent laws mandating drug and alcohol testing
5.2.1.3 Increasing number of regulatory approvals for drug screening products and services
TABLE 3 KEY PRODUCT AND SERVICE LAUNCHES FOR DRUG AND ALCOHOL TESTING, 2020–2022
TABLE 4 LIST OF REGULATORY AUTHORITIES FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
5.2.2 RESTRAINTS
5.2.2.1 Ban on alcohol consumption in Islamic countries
5.2.2.2 Prohibition on workplace drug testing
5.2.3 OPPORTUNITIES
5.2.3.1 Popularity of oral fluid testing
5.2.3.2 Introduction of fingerprint-based drug testing at workplaces
5.2.3.3 High growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Accuracy and specificity concerns in breathalyzers
5.2.4.2 False positive and negative results in drug screening
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 28 SHIFTS AND NEW REVENUE POCKETS FOR MARKET
5.4 INDUSTRY TRENDS
5.4.1 INCREASING USE OF ORAL FLUID TESTING
5.4.2 GROWING NEED FOR SUBSTANCE TESTING PANELS
5.4.3 TECHNOLOGICAL ADVANCEMENTS
5.4.4 RISING FOCUS ON EMPLOYEE WELLNESS
5.5 VALUE CHAIN ANALYSIS
FIGURE 29 MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 30 MARKET: ECOSYSTEM MAP
TABLE 5 MARKET: ROLE IN ECOSYSTEM
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Sweat patch testing
5.7.1.2 Alcohol ignition interlock device
5.7.1.3 Point-of-care testing
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Artificial Intelligence and machine learning
5.7.2.2 Biosensors
5.8 PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 INTENSITY OF COMPETITIVE RIVALRY
5.8.2 BARGAINING POWER OF SUPPLIERS
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 THREAT OF SUBSTITUTES
5.8.5 THREAT OF NEW ENTRANTS
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
5.9.2 KEY BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 8 KEY BUYING CRITERIA FOR TOP THREE END USERS
5.10 TARIFF AND REGULATORY ANALYSIS
5.10.1 TARIFF ANALYSIS
5.10.1.1 Tariff of chromatography instruments (HS code: 902720)
TABLE 9 TARIFF FOR CHROMATOGRAPHY INSTRUMENTS (HS CODE: 902720)
5.10.2 REGULATORY ANALYSIS
5.10.2.1 North America
5.10.2.1.1 US
TABLE 10 US: DRUG AND ALCOHOL TESTING REGULATIONS
5.10.2.2 Europe
5.10.2.2.1 Finland
5.10.2.2.2 Sweden
5.10.2.2.3 France
5.10.2.2.4 Italy
5.10.2.2.5 UK
5.10.2.2.6 Netherlands
5.10.2.2.7 Ireland
5.10.2.3 Asia Pacific
5.10.2.3.1 Japan
5.10.2.3.2 China
5.10.2.3.3 India
5.10.2.4 Australia and New Zealand
5.10.2.5 Latin America
5.10.2.6 Middle East & Africa
5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
FIGURE 34 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
TABLE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.11.2 INDICATIVE PRICING ANALYSIS
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS FOR DRUG SCREENING PRODUCTS
FIGURE 35 PATENT PUBLICATION TRENDS IN MARKET (JANUARY 2012–DECEMBER 2023)
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DRUG SCREENING PATENTS (JANUARY 2012–NOVEMBER 2023)
FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR DRUG SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)
TABLE 17 MARKET: LIST OF MAJOR PATENTS
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025
TABLE 18 MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS
5.14 CASE STUDY ANALYSIS
5.14.1 LEADING RETAIL CHAIN TO SAVE USD 1 MILLION WITH INSTANT ORAL FLUID DRUG SCREENING SOLUTIONS
5.14.2 PRE-EMPLOYMENT TESTING IN LONG-TERM CARE INDUSTRY
5.14.3 USE OF HAIR TESTING AND URINALYSIS IN TRANSPORTATION INDUSTRY
5.14.4 RANDOM TESTING IN MANUFACTURING AND AUTOMOTIVE INDUSTRIES
5.15 REVENUE MODEL ANALYSIS
5.15.1 SERVICE FEES
5.15.2 PRODUCT SALES
5.15.3 SERVICE PACKAGES
5.16 END USER ANALYSIS
5.16.1 UNMET NEEDS
TABLE 19 UNMET NEEDS IN MARKET
5.16.2 END USER EXPECTATIONS
TABLE 20 END USER EXPECTATIONS IN MARKET
5.17 FUNDING LANDSCAPE
FIGURE 38 FUNDING OF KEY PLAYERS IN MARKET
5.18 TRADE ANALYSIS
FIGURE 39 IMPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019–2023 (USD)
FIGURE 40 EXPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019–2023 (USD MILLION)
6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE (Page No. - 137)
6.1 INTRODUCTION
TABLE 21 DRUG SCREENING INDUSTRY, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 22 DRUG SCREENING INDUSTRY, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
6.2 DRUG SCREENING SERVICES
TABLE 23 DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 24 DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 25 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 26 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.2.1 LABORATORY TESTING SERVICES
6.2.1.1 Higher accuracy and better reliability to propel segment growth
TABLE 27 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 28 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.2.2 ON-SITE TESTING SERVICES
6.2.2.1 Increasing emphasis on workplace safety to drive market
TABLE 29 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 30 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3 DRUG SCREENING PRODUCTS
TABLE 31 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 32 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 33 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 34 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1 ANALYTICAL INSTRUMENTS
6.3.1.1 Analytical instruments market, by type
TABLE 35 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 36 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 37 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 38 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.1.1 Breathalyzers
TABLE 39 BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 40 BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 41 BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 42 BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.1.1.1 Fuel-cell breathalyzers
6.3.1.1.1.1.1 High accuracy, sensitivity, and reliability to support segment growth
TABLE 43 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 44 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.1.1.2 Semiconductor breathalyzers
6.3.1.1.1.2.1 Low cost and high accuracy to aid segment growth
TABLE 45 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 46 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.1.1.3 Other breathalyzers
TABLE 47 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 48 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.1.2 Immunoassay analyzers
6.3.1.1.2.1 Technological advancements and high demand for drug testing to drive segment
TABLE 49 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 50 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.1.3 Chromatography instruments
6.3.1.1.3.1 More flexibility and higher accuracy to fuel segment growth
TABLE 51 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 52 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.2 Analytical instruments market, by modality
TABLE 53 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 54 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 55 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 56 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.2.1 Hand-held drug screening products
6.3.1.2.1.1 Rising need for quick alcohol intoxication level assessment to drive segment
TABLE 57 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 58 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.1.2.2 Benchtop drug screening products
6.3.1.2.2.1 High sensitivity and specificity to different drugs at low concentrations to boost segment growth
TABLE 59 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 60 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.2 RAPID TESTING DEVICES
TABLE 61 RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 62 RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 63 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 64 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.2.1 Urine testing devices
TABLE 65 URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 66 URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 67 URINE TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 68 URINE TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.2.1.1 Drug testing cups
6.3.2.1.1.1 Reduced chances of sample contamination to drive segment
TABLE 69 DRUG TESTING CUPS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 70 DRUG TESTING CUPS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.2.1.2 Dip cards
6.3.2.1.2.1 No instrument requirements during urine testing to boost segment growth
TABLE 71 DIP CARDS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 72 DIP CARDS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.2.1.3 Drug testing cassettes
6.3.2.1.3.1 Cost-effectiveness and quick results to augment segment growth
TABLE 73 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 74 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.2.2 Oral fluid testing devices
6.3.2.2.1 Low possibility of sample tampering to aid market growth
TABLE 75 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 76 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.3 CONSUMABLES
TABLE 77 CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 78 CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 79 CONSUMABLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 80 CONSUMABLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.3.1 Assay kits
6.3.3.1.1 Increased focus on rapid, inexpensive, and convenient sample screening methods to drive market
TABLE 81 ASSAY KITS MARKET, BY COUNTRY 2018–2022 (USD MILLION)
TABLE 82 ASSAY KITS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.3.2 Sample collection devices
6.3.3.2.1 Rising need for safe and efficient sample collection and transportation to propel market growth
TABLE 83 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 84 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.3.3 Calibrators and controls
6.3.3.3.1 Growing need for quantitative comparison with actual test samples to fuel market growth
TABLE 85 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 86 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
6.3.3.4 Other consumables
TABLE 87 OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 88 OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
7 DRUG SCREENING MARKET, BY SAMPLE TYPE (Page No. - 191)
7.1 INTRODUCTION
TABLE 89 DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 90 MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
7.2 URINE SAMPLES
7.2.1 EASE OF COLLECTION AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
TABLE 91 MARKET FOR URINE SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 92 MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
7.3 BREATH SAMPLES
7.3.1 RISING NUMBER OF DRIVING-UNDER-INFLUENCE CASES TO PROPEL MARKET GROWTH
TABLE 93 MARKET FOR BREATH SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 94 MARKET FOR BREATH SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
7.4 ORAL FLUID SAMPLES
7.4.1 NON-INVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION TO BOOST MARKET GROWTH
TABLE 95 MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 96 MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
7.5 HAIR SAMPLES
7.5.1 DETAILED INSIGHTS INTO LONG-TERM DRUG USE TO SPUR MARKET GROWTH
TABLE 97 MARKET FOR HAIR SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 98 MARKET FOR HAIR SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
7.6 OTHER SAMPLES
TABLE 99 MARKET FOR OTHER SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 100 MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
8 DRUG SCREENING MARKET, BY DRUG TYPE (Page No. - 203)
8.1 INTRODUCTION
TABLE 101 DRUG SCREENING INDUSTRY, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 102 MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
8.2 CANNABIS
8.2.1 INCREASING LEGALIZATION FOR MEDICAL AND RECREATIONAL PURPOSES TO DRIVE MARKET
TABLE 103 MARKET FOR CANNABIS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 104 MARKET FOR CANNABIS, BY COUNTRY, 2023–2029 (USD MILLION)
8.3 ALCOHOL
8.3.1 RISING REGULATORY COMPLIANCE IN SAFETY-SENSITIVE INDUSTRIES TO DRIVE MARKET
TABLE 105 MARKET FOR ALCOHOL, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 106 MARKET FOR ALCOHOL, BY COUNTRY, 2023–2029 (USD MILLION)
8.4 COCAINE
8.4.1 ILLICIT NATURE AND ASSOCIATED HEALTH RISKS TO FUEL MARKET GROWTH
TABLE 107 MARKET FOR COCAINE, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 108 MARKET FOR COCAINE, BY COUNTRY, 2023–2029 (USD MILLION)
8.5 OPIOIDS
8.5.1 INCREASING CASES OF OPIOIDS ADDICTION TO AID MARKET GROWTH
TABLE 109 MARKET FOR OPIOIDS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 110 MARKET FOR OPIOIDS, BY COUNTRY, 2023–2029 (USD MILLION)
8.6 AMPHETAMINE AND METHAMPHETAMINE
8.6.1 GROWING USE AMONG EDUCATION SERVICE EMPLOYEES TO AUGMENT MARKET GROWTH
TABLE 111 MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 112 MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2023–2029 (USD MILLION)
8.7 OTHER DRUGS
TABLE 113 MARKET FOR OTHER DRUGS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 114 MARKET FOR OTHER DRUGS, BY COUNTRY, 2023–2029 (USD MILLION)
9 DRUG SCREENING MARKET, BY END USER (Page No. - 216)
9.1 INTRODUCTION
TABLE 115 DRUG SCREENING INDUSTRY, BY END USER, 2018–2022 (USD MILLION)
TABLE 116 MARKET, BY END USER, 2023–2029 (USD MILLION)
9.2 DRUG TESTING LABORATORIES
9.2.1 DRUG TESTING LABORATORIES TO COMMAND HIGHEST GROWTH RATE DURING STUDY PERIOD
TABLE 117 MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 118 MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2023–2029 (USD MILLION)
9.3 WORKPLACES
9.3.1 INCREASED FOCUS ON RANDOM DRUG TESTING AT OFFICES TO FUEL MARKET GROWTH
TABLE 119 MARKET FOR WORKPLACES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 120 MARKET FOR WORKPLACES, BY COUNTRY, 2023–2029 (USD MILLION)
9.4 CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES
9.4.1 GROWING GOVERNMENT FOCUS ON DRUG TESTING TO DRIVE MARKET
TABLE 121 MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 122 MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2023–2029 (USD MILLION)
9.5 HOSPITALS
9.5.1 RISING DRUG ABUSE CASES TO AID MARKET GROWTH
TABLE 123 MARKET FOR HOSPITALS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 124 MARKET FOR HOSPITALS, BY COUNTRY, 2023–2029 (USD MILLION)
9.6 DRUG TREATMENT CENTERS
9.6.1 GROWING GOVERNMENT SUPPORT AGAINST DRUG ABUSE TO DRIVE MARKET
TABLE 125 DRUG SCREENING INDUSTRY FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 126 MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
9.7 INDIVIDUAL USERS
9.7.1 STRINGENT REGULATIONS AND PERSONAL SAFETY CONCERNS TO DRIVE MARKET
TABLE 127 MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 128 MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2023–2029 (USD MILLION)
9.8 PAIN MANAGEMENT CENTERS
9.8.1 GROWING ABUSE OF PRESCRIPTION DRUGS TO DRIVE MARKET
TABLE 129 MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 130 MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
9.9 SCHOOLS AND COLLEGES
9.9.1 RISING FOCUS ON DRUG ABUSE TESTING PROGRAMS TO SUPPORT MARKET GROWTH
TABLE 131 MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 132 MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2023–2029 (USD MILLION)
9.10 OTHER END USERS
TABLE 133 MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 134 MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION)
10 DRUG SCREENING MARKET, BY REGION (Page No. - 237)
10.1 INTRODUCTION
TABLE 135 DRUG SCREENING INDUSTRY, BY REGION, 2018–2022 (USD MILLION)
TABLE 136 DRUG SCREENING INDUSTRY, BY REGION, 2023–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 41 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT
TABLE 137 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 138 NORTH AMERICA: MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 139 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 140 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 141 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 142 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 143 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 144 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 145 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 146 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 147 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 148 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 150 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 151 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 152 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 153 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 154 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 155 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 156 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 158 NORTH AMERICA: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 159 NORTH AMERICA: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 160 NORTH AMERICA: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 161 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 162 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 US to dominate North American drug screening market during study period
TABLE 163 US: MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 164 US: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 165 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 166 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 167 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 168 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 169 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 170 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 171 US: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 172 US: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 173 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 174 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 175 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 176 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 177 US: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 178 US: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 179 US: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 180 US: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 181 US: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 182 US: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 183 US: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 184 US: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 185 US: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 186 US: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increasing drunk driving-related accidental deaths to support market growth
TABLE 187 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 188 CANADA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 189 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 190 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 191 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 192 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 193 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 194 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 195 CANADA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 196 CANADA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 197 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 198 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 199 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 200 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 201 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 202 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 203 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 204 CANADA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 205 CANADA: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 206 CANADA: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 207 CANADA: DRUG SCREENING INDUSTRY, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 208 CANADA: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 209 CANADA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 210 CANADA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3 EUROPE
TABLE 211 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 212 EUROPE: MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 213 EUROPE: MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 214 EUROPE: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 215 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 216 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 217 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 218 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 219 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 220 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 221 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 222 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 223 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 224 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 225 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 226 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 227 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 228 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 229 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 230 EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 231 EUROPE: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 232 EUROPE: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 233 EUROPE: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 234 EUROPE: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 235 EUROPE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 236 EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing number of drug-related deaths to drive market
TABLE 237 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 238 GERMANY: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 239 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 240 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 241 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 242 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 243 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 244 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 245 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 246 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 247 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 248 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 249 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 250 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 251 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 252 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 253 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 254 GERMANY: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 255 GERMANY: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 256 GERMANY: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 257 GERMANY: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 258 GERMANY: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 259 GERMANY: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 260 GERMANY: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Robust healthcare infrastructure and proactive approach toward public health to aid market growth
TABLE 261 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 262 FRANCE: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 263 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 264 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 265 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 266 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 267 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 268 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 269 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 270 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 271 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 272 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 273 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 274 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 275 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 276 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 277 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 278 FRANCE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 279 FRANCE: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 280 FRANCE: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 281 FRANCE: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 282 FRANCE: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 283 FRANCE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 284 FRANCE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3.4 UK
10.3.4.1 Increase in illicit drug consumption to augment market growth
TABLE 285 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 286 UK: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 287 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 288 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 289 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 290 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 291 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 292 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 293 UK: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 294 UK: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 295 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 296 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 297 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 298 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 299 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 300 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 301 UK: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 302 UK: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 303 UK: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 304 UK: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 305 UK: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 306 UK: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 307 UK: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 308 UK: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Growing consumption of illegal psychoactive substances and drugs among minors to boost market growth
TABLE 309 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 310 ITALY: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 311 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 312 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 313 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 314 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 315 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 316 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 317 ITALY: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 318 ITALY: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 319 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 320 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 321 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 322 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 323 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 324 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 325 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 326 ITALY: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 327 ITALY: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 328 ITALY: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 329 ITALY: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 330 ITALY: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 331 ITALY: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 332 ITALY: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Stringent government regulations and high consumption of alcohol to aid market growth
TABLE 333 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 334 SPAIN: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 335 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 336 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 337 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 338 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 339 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 340 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 341 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 342 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 343 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 344 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 345 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 346 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 347 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 348 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 349 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 350 SPAIN: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 351 SPAIN: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 352 SPAIN: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 353 SPAIN: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 354 SPAIN: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 355 SPAIN: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 356 SPAIN: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 357 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 358 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 359 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 360 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 361 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 362 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 363 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, 2018–2022 (USD MILLION)
TABLE 364 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 365 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 366 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 367 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 368 REST OF EUROPE ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 369 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 370 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 371 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 372 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 373 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 374 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 375 REST OF EUROPE: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 376 REST OF EUROPE: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 377 REST OF EUROPE: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 378 REST OF EUROPE: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 379 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 380 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 42 ASIA PACIFIC: DRUG SCREENING MARKET SNAPSHOT
TABLE 381 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 382 ASIA PACIFIC: MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 383 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 384 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 385 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 386 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 387 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 388 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 389 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 390 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 391 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 392 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 393 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 394 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 395 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 396 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 397 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 398 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 399 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 400 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 401 ASIA PACIFIC: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 402 ASIA PACIFIC: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 403 ASIA PACIFIC: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 404 ASIA PACIFIC: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 405 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 406 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Stringent laws for drug abuse and increased government support to drive market
TABLE 407 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 408 JAPAN: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 409 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 410 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 411 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 412 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 413 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 414 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 415 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 416 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 417 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 418 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 419 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 420 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 421 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 422 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 423 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 424 JAPAN: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 425 JAPAN: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 426 JAPAN: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 427 JAPAN: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 428 JAPAN: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 429 JAPAN: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 430 JAPAN: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Increasing alcohol consumption and rising cases of drunk driving to fuel market growth
TABLE 431 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 432 CHINA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 433 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 434 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 435 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 436 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 437 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 438 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 439 CHINA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 440 CHINA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 441 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 442 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 443 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 444 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 445 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 446 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 447 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 448 CHINA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 449 CHINA: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 450 CHINA: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 451 CHINA: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 452 CHINA: MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 453 CHINA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 454 CHINA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Increase in illicit drug users and improved healthcare infrastructure to support market growth
TABLE 455 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 456 INDIA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 457 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 458 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 459 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 460 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 461 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 462 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 463 INDIA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 464 INDIA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 465 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 466 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 467 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 468 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 469 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 470 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 471 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 472 INDIA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 473 INDIA: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 474 INDIA: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 475 INDIA: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 476 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 477 INDIA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 478 INDIA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 479 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 480 REST OF ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 481 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 482 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 483 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 484 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 485 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 486 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 487 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 488 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 489 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 490 REST OF ASIA PACIFIC ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 491 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 492 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 493 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 494 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 495 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 496 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 497 REST OF ASIA PACIFIC: MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 498 REST OF ASIA PACIFIC: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 499 REST OF ASIA PACIFIC: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 500 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 501 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 502 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.5 LATIN AMERICA
TABLE 503 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 504 LATIN AMERICA: MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
TABLE 505 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 506 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 507 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 508 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 509 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 510 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 511 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 512 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 513 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 514 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 515 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 516 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 517 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 518 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 519 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 520 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 521 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 522 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 523 LATIN AMERICA: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 524 LATIN AMERICA: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 525 LATIN AMERICA: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 526 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 527 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 528 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Growing emphasis on substance abuse prevention at workplaces to drive market
TABLE 529 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 530 BRAZIL: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 531 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 532 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 533 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 534 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 535 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 536 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 537 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 538 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 539 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 540 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 541 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 542 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 543 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 544 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 545 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 546 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 547 BRAZIL: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 548 BRAZIL: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 549 BRAZIL: MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 550 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 551 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 552 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Increasing government focus on controlling drug trafficking and substance abuse to propel market growth
TABLE 553 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 554 MEXICO: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 555 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 556 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 557 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 558 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 559 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 560 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 561 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 562 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 563 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 564 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 565 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 566 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 567 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 568 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 569 MEXICO: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 570 MEXICO: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 571 MEXICO: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 572 MEXICO: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 573 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 574 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 575 MEXICO: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 576 MEXICO: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 577 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 578 REST OF LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 579 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 580 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 581 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 582 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 583 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 584 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 585 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 586 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 587 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 588 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 589 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 590 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 591 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 592 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 593 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 594 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 595 REST OF LATIN AMERICA: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 596 REST OF LATIN AMERICA: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 597 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 598 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 599 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 600 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
TABLE 601 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 602 MIDDLE EAST & AFRICA: MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 603 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 604 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 605 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 606 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 607 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 608 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 609 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 610 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 611 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 612 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 613 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 614 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 615 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 616 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 617 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 618 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 619 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 620 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 621 MIDDLE EAST & AFRICA: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 622 MIDDLE EAST & AFRICA: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 623 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 624 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 625 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 626 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
10.6.2 GCC COUNTRIES
10.6.2.1 Technological advancements in drug screening to drive market
TABLE 627 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 628 GCC COUNTRIES: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 629 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 630 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 631 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 632 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 633 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 634 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 635 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 636 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 637 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 638 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 639 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 640 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 641 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 642 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 643 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 644 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 645 GCC COUNTRIES: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 646 GCC COUNTRIES: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 647 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 648 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 649 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 650 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
10.6.3 REST OF MIDDLE EAST & AFRICA
TABLE 651 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
TABLE 652 REST OF MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
TABLE 653 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 654 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 655 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 656 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 657 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 658 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 659 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 660 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 661 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 662 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 663 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 664 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 665 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 666 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 667 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 668 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 669 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING INDUSTRY, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
TABLE 670 REST OF MIDDLE EAST & AFRICA: MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
TABLE 671 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
TABLE 672 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
TABLE 673 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 674 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 445)
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
FIGURE 43 DRUG SCREENING MARKET: STRATEGIES ADOPTED
11.3 REVENUE ANALYSIS
FIGURE 44 DRUG SCREENING INDUSTRY: REVENUE ANALYSIS (2019–2023)
11.4 MARKET SHARE ANALYSIS
FIGURE 45 DRUG SCREENING INDUSTRY: MARKET SHARE ANALYSIS (2023)
TABLE 675 DRUG SCREENING INDUSTRY: DEGREE OF COMPETITION
11.4.1 MARKET RANKING ANALYSIS
FIGURE 46 DRUG SCREENING INDUSTRY RANKING, BY KEY PLAYER (2023)
11.4.1.1 Laboratory Corporation of America Holdings
11.4.1.2 Quest Diagnostics
11.4.1.3 Abbott
11.5 BRAND/PRODUCT COMPARISON
FIGURE 47 DRUG SCREENING INDUSTRY: BRAND/PRODUCT COMPARISON
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 48 DRUG SCREENING INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.6.5.1 Overall footprint
TABLE 676 DRUG SCREENING INDUSTRY: OVERALL FOOTPRINT
11.6.5.2 Product footprint
TABLE 677 DRUG SCREENING INDUSTRY: PRODUCT FOOTPRINT
11.6.5.3 Service footprint
TABLE 678 DRUG SCREENING INDUSTRY: SERVICE FOOTPRINT
11.6.5.4 Sample type footprint
TABLE 679 DRUG SCREENING MARKET: SAMPLE TYPE FOOTPRINT
11.6.5.5 Drug type footprint
TABLE 680 DRUG SCREENING MARKET: DRUG TYPE FOOTPRINT
11.6.5.6 Regional footprint
TABLE 681 DRUG SCREENING MARKET: REGIONAL FOOTPRINT
11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
11.7.1 PROGRESSIVE COMPANIES
11.7.2 RESPONSIVE COMPANIES
11.7.3 DYNAMIC COMPANIES
11.7.4 STARTING BLOCKS
FIGURE 49 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
11.7.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
TABLE 682 DRUG SCREENING MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 683 DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
11.8 VALUATION AND FINANCIAL METRICS
FIGURE 50 EV/EBITDA OF KEY VENDORS
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS
TABLE 684 DRUG SCREENING MARKET: PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS, JANUARY 2021–APRIL 2024
11.9.2 DEALS
TABLE 685 DRUG SCREENING MARKET: DEALS, JANUARY 2021–APRIL 2024
11.9.3 OTHER DEVELOPMENTS
TABLE 686 DRUG SCREENING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2024
12 COMPANY PROFILES (Page No. - 467)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
TABLE 687 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
FIGURE 52 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)
TABLE 688 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 689 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS
12.1.2 QUEST DIAGNOSTICS
TABLE 690 QUEST DIAGNOSTICS: COMPANY OVERVIEW
FIGURE 53 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)
TABLE 691 QUEST DIAGNOSTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 692 QUEST DIAGNOSTICS: SERVICE LAUNCHES
TABLE 693 QUEST DIAGNOSTICS: DEALS
12.1.3 ABBOTT
TABLE 694 ABBOTT: COMPANY OVERVIEW
FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2023)
TABLE 695 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.4 ORASURE TECHNOLOGIES INC.
TABLE 696 ORASURE TECHNOLOGIES INC.: COMPANY OVERVIEW
FIGURE 55 ORASURE TECHNOLOGIES INC.: COMPANY SNAPSHOT (2023)
TABLE 697 ORASURE TECHNOLOGIES INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 698 ORASURE TECHNOLOGIES INC.: DEALS
12.1.5 ALFA SCIENTIFIC DESIGNS INC.
TABLE 699 ALFA SCIENTIFIC DESIGNS INC.: COMPANY OVERVIEW
TABLE 700 ALFA SCIENTIFIC DESIGNS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.6 THERMO FISHER SCIENTIFIC INC.
TABLE 701 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
TABLE 702 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 703 THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS
TABLE 704 THERMO FISHER SCIENTIFIC INC.: DEALS
12.1.7 DRÄGERWERK AG & CO. KGAA
TABLE 705 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 57 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
TABLE 706 DRÄGERWERK AG & CO. KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 707 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES AND APPROVALS
12.1.8 LIFELOC TECHNOLOGIES, INC.
TABLE 708 LIFELOC TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 58 LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 709 LIFELOC TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.9 MPD INC.
TABLE 710 MPD INC.: COMPANY OVERVIEW
TABLE 711 MPD INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.10 OMEGA LABORATORIES, INC.
TABLE 712 OMEGA LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 713 OMEGA LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 714 OMEGA LABORATORIES, INC.: SERVICE LAUNCHES
TABLE 715 OMEGA LABORATORIES, INC.: DEALS
TABLE 716 OMEGA LABORATORIES, INC.: OTHER DEVELOPMENTS
12.1.11 PREMIER BIOTECH, INC.
TABLE 717 PREMIER BIOTECH, INC.: COMPANY OVERVIEW
TABLE 718 PREMIER BIOTECH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.12 PSYCHEMEDICS CORPORATION
TABLE 719 PSYCHEMEDICS CORPORATION: COMPANY OVERVIEW
FIGURE 59 PSYCHEMEDICS CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 720 PSYCHEMEDICS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.13 F. HOFFMANN-LA ROCHE LTD.
TABLE 721 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
FIGURE 60 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
TABLE 722 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.14 SHIMADZU CORPORATION
TABLE 723 SHIMADZU CORPORATION: COMPANY OVERVIEW
FIGURE 61 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 724 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 725 SHIMADZU CORPORATION: PRODUCT LAUNCHES
12.1.15 SIEMENS HEALTHINEERS AG
TABLE 726 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
TABLE 727 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 728 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES
TABLE 729 SIEMENS HEALTHINEERS AG: DEALS
12.2 OTHER PLAYERS
12.2.1 AMERICAN BIO MEDICA CORPORATION
TABLE 730 AMERICAN BIO MEDICA CORPORATION: COMPANY OVERVIEW
12.2.2 ACM GLOBAL LABORATORIES
TABLE 731 ACM GLOBAL LABORATORIES: COMPANY OVERVIEW
12.2.3 CAREHEALTH AMERICA CORP.
TABLE 732 CAREHEALTH AMERICA CORP.: COMPANY OVERVIEW
12.2.4 CLINICAL REFERENCE LABORATORY, INC.
TABLE 733 CLINICAL REFERENCE LABORATORY, INC.: COMPANY OVERVIEW
12.2.5 INTOXIMETERS
TABLE 734 INTOXIMETERS: COMPANY OVERVIEW
12.2.6 SCITECK, INC.
TABLE 735 SCITECK, INC.: COMPANY OVERVIEW
12.2.7 ACCUSOURCEHR, INC.
TABLE 736 ACCUSOURCEHR, INC.: COMPANY OVERVIEW
12.2.8 CORDANT HEALTH SOLUTIONS
TABLE 737 CORDANT HEALTH SOLUTIONS: COMPANY OVERVIEW
12.2.9 INTOXALOCK
TABLE 738 INTOXALOCK: COMPANY OVERVIEW
12.2.10 MILLENNIUM HEALTH
TABLE 739 MILLENNIUM HEALTH: COMPANY OVERVIEW
12.2.11 ADVACARE PHARMA
TABLE 740 ADVACARE PHARMA: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 525)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
Growth opportunities and latent adjacency in Drug Screening Market